[Congressional Record Volume 156, Number 163 (Friday, December 10, 2010)]
[Senate]
[Pages S8734-S8735]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
RECOGNIZING FEDERAL EMPLOYEE
Deborah Autor
Mr. WARNER. Mr. President, I rise again to recognize the service of
another great Federal employee. This is a tradition that was started by
our friend and former colleague, Senator Kaufman, and I am proud to
carry on that tradition. But I want to first say that I appreciate the
remarks of the Presiding Officer about our colleagues who are leaving
this body, and I share his great respect for not only Senator Kaufman
but all of the colleagues who are leaving the body at the end of this
Congress.
Mr. President, oftentimes we forget that thousands of Federal
employees go to work every day with the sole mission of making this
country a safer place to live. Ms. Deborah Autor is one of those
employees.
As we enter into the cold and flu season, there is great concern
about harmful medications that may fall into the hands of our children
or other loved ones. As Director of the Food and Drug Administration's
Drug Compliance Office, Ms. Autor works to protect public health by
minimizing Americans' exposure to unsafe, ineffective, and poor-quality
drugs that enter the marketplace.
Ms. Autor is particularly focused on removing potentially dangerous
prescription medicines, including cough medicines, anti-inflammatory
drugs, antihistamines, and migraine medications, just to name a few.
Under her leadership, the FDA has taken enforcement action to remove
more than 500 unapproved prescription drugs from the market. She is
also credited with designing a program used to identify unapproved
drugs, evaluate the public health consequences, and explore any
potential legal challenges.
Many believe Ms. Autor is the brains behind the FDA's aggressive
enforcement efforts. In conducting the research for these remarks, we
found a quote from Mr. Steven Galson, a former Acting U.S. Surgeon
General, and this is what he had to say about Ms. Autor:
She developed the program under budget constraints,
withstood scrutiny and criticism from some in the drug
industry and
[[Page S8735]]
Congress, successfully navigated the internal FDA process and
took aggressive action to clamp down on illegal drug
marketers.
There are many others who have sung her praises and highlighted her
commitment to public service.
Prior to work at the FDA, Ms. Autor was a trial attorney for the
Office of Consumer Litigation at the Department of Justice, where she
served for 7 years. In this role, she litigated civil and criminal
cases on behalf of the FDA.
I hope my colleagues will join me in honoring Ms. Autor for her
dedicated public service and important contributions to our Nation's
health and safety.
I would also add that in these challenging fiscal times, as we
approach and go through the holiday season, I hope we all recognize the
enormous contribution all of our Federal employees make. The Presiding
Officer many times reminds all of us of the enormous role our men and
women in the armed services play, and our thoughts and prayers are with
all of them. But I think it is also important to recognize these great
Federal employees such as Ms. Autor and literally the countless others
who oftentimes--and sometimes at the disdain of folks in elective
office--are the folks who provide enormous public service to all
Americans. So I hope we keep them in our thoughts as well during this
holiday season.
Before I conclude my remarks, I also wish to thank my friend, the
Senator from Vermont, who is a passionate advocate for trying to end
the growing income inequality in this country. I know he is going to be
making some impassioned comments, and I appreciate his giving me a
couple of moments to recognize this Federal employee, and I look
forward to hearing his comments.
With that, Mr. President, I yield the floor.
The PRESIDING OFFICER. The Senator from Vermont.
____________________